Atrium C-Qur Hernia Mesh Bellwether Trials May Be Pushed Back to Start in 2021

The U.S. District Judge presiding over all Atrium C-Qur hernia mesh lawsuits is considering whether to delay the start of the first bellwether trial until the beginning of next year, due to delays and disruptions caused by the ongoing coronavirus outbreak.

There are nearly 2,000 product liability lawsuits filed against Atrium Medical Corp. throughout the federal court system, each involving similar allegations that plaintiffs experienced problems with a hernia mesh system known as C-Qur (pronounced “secure”), which featured a unique polypropylene patch design with an an Omega-3 fatty acid (O3FA) gel coating.

While this design was intended to reduce scar tissue formation and promote fixation of the mesh to the abdominal wall, plaintiffs claim the C-Qur patch actually increased the risk of an inflammatory response, bowel adhesions and other painful complications, often resulting in additional surgery.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More About this Lawsuit See If You Qualify For Compensation

Given similar questions of fact and law raised in the complaints brought throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for all Atrium C-Qur hernia mesh cases in December 2016, centralizing the cases before U.S. District Judge Landya McCafferty in New Hampshire, for coordinating discovery, pretrial rulings and a “bellwether” process, where a group of representative claims have been prepared for trial to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the cases.

Currently the first trial is scheduled to begin on May 20, and the parties have been discussing the potential for a new trial date as a result of disruptions to the judicial process caused by the COVID-19 pandemic, but have not yet reached an agreement.

In a motion (PDF) filed on April 8, Atrium asked the court to delay the start of the trial more than six months, pushing the case into January 2021 and extending all pretrial deadlines by about 90 days.

The manufacturer has asked for an expedited consideration of the motion, given the fast-approaching deadlines associated with the original trial date. Plaintiffs have been directed to file a response on or before April 16, and the Court has continued deadlines set for selecting the final trial cases that were supposed to be designated this week.

While the outcomes of these “bellwether” trials will not be binding on other claims, the process is designed to facilitate potential hernia mesh settlements that may be necessary to avoid the need for hundreds of individual trials in various U.S. District Courts nationwide following the coordinated MDL proceedings.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.